Loading…
GH Research PLC is projected to rise to $42.65 by 2027, a +61% move from its current price of $26.51. GHRS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $25.65 | $26.53 | $27.43 | +0.06% |
| Jul 15 | $25.32 | $26.54 | $27.83 | +0.13% |
| Jul 16 | $25.06 | $26.56 | $28.15 | +0.19% |
| Jul 17 | $24.85 | $26.58 | $28.42 | +0.26% |
| Jul 18 | $24.67 | $26.60 | $28.67 | +0.32% |
| Jul 19 | $24.51 | $26.61 | $28.89 | +0.39% |
| Jul 20 | $24.37 | $26.63 | $29.10 | +0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.37 | $26.63 | $29.10 | +0.45% |
| Week 2 | $23.60 | $26.75 | $30.32 | +0.90% |
| Week 3 | $23.04 | $26.87 | $31.33 | +1.36% |
| Week 4 | $22.60 | $26.99 | $32.23 | +1.81% |
| Week 5 | $22.24 | $27.11 | $33.06 | +2.27% |
| Week 6 | $21.92 | $27.23 | $33.84 | +2.73% |
| Week 7 | $21.64 | $27.36 | $34.59 | +3.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders.
The company was founded in 2018 and is based in Dublin, Ireland.
GHRS trades at $26.17 with a market cap of $1.8B and is ranked 2103. The 30-day range is $20.51 to $33.39. The price outlook for 2026 shows an average of $26.17 with NEUTRAL sentiment, a min of $13.03 and a max of $39.37.
From 2027 onward the forecast envisions growth, with 2027 avg $42.80 and 2030 avg $62.49, and by 2050 the average is $502.66, with BULLISH sentiment continuing through 2050. The max forecast values rise to $97.42 by 2030 and to $1,051.50 by 2050.
A major floor 50.8% below — a decisive break under it would weaken the trend.
The nearest floor, 24.6% below — buyers have tended to step in here.
The nearest ceiling, 7.5% above — a clean break opens room to run.
A major ceiling 26.4% above — clearing it would confirm fresh momentum.
Key GHRS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GHRS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $26.72 | Sell | $26.75 | Sell |
| MA 10 | $27.06 | Sell | $26.35 | Buy |
| MA 20 | $24.62 | Buy | $25.27 | Buy |
| MA 50 | $23.01 | Buy | $23.00 | Buy |
| MA 100 | $19.46 | Buy | $20.60 | Buy |
| MA 200 | $16.87 | Buy | $17.98 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.58 | Neutral |
| Stoch RSI (14) | 27.53 | Neutral |
| CCI (20) | 50.09 | Neutral |
| Williams %R (14) | -30.94 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 12.28 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 69.06 | Neutral |
| TRIX (15) | 0.81 | Buy |
| Awesome (5,34) | 2.97 | Buy |
| Ultimate (7,14,28) | 53.11 | Neutral |
| Momentum (10) | 1.17 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 26.84 | Sell |
| ADX (14) | 24.26 | Buy |
| ATR (14) | 0.75 | Info |
The 30-day technical picture is BULLISH, with RSI(14) at 60. The SMA50 is $22.43 and the SMA200 is $16.59, framing a constructive near-term trend. Annualized volatility is 70%. Support is seen at $19.98 and resistance at $28.49, with the 30-day price range running from $20.51 to $33.39.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.03 | $26.51 | $39.17 | 0% | Neutral | |
| $33.24 | $42.65 | $58.31 | +61% | Bullish | |
| $37.08 | $49.28 | $70.40 | +86% | Bullish | |
| $42.67 | $58.39 | $86.31 | +120% | Bullish | |
| $45.09 | $63.33 | $96.34 | +139% | Bullish | |
| $49.17 | $70.73 | $110.31 | +167% | Bullish | |
| $59.98 | $88.23 | $140.68 | +233% | Bullish | |
| $68.25 | $102.53 | $166.81 | +287% | Bullish | |
| $84.86 | $130.07 | $215.54 | +391% | Bullish | |
| $98.80 | $154.37 | $260.23 | +482% | Bullish | |
| $149.40 | $255.09 | $461.68 | +862% | Bullish | |
| $256.66 | $513.05 | $1,028.71 | +18.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.03 | $26.51 | $32.44 | +0.00% |
| August 2026 | $23.82 | $28.28 | $34.58 | +6.66% |
| September 2026 | $23.47 | $28.11 | $34.85 | -0.59% |
| October 2026 | $23.06 | $27.82 | $34.89 | -1.02% |
| November 2026 | $24.09 | $29.25 | $37.03 | +5.15% |
| December 2026 | $25.11 | $30.67 | $39.17 | +4.85% |
Click any year to see its month-by-month GHRS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GHRS could reach as high as $39.17, with a base case around $26.51 and support toward $13.03 — roughly 0% from $26.51. A consolidation phase looks the most probable path here.
Expect GHRS to range from $33.24 to $58.31 through 2027. The $42.65 average target implies a +61% move from current prices. That is up +61% on the projected 2026 average. Momentum favours further upside here.
The GHRS price prediction for 2028 points to an average of $49.28 (low $37.08, high $70.40) — a potential gain of +86% on today's $26.51. Buyers look set to stay in control over this stretch.
In 2029, GHRS is projected to trade between $42.67 and $86.31, averaging $58.39 — a potential gain of +120% from today's $26.51. That is up +18% on the projected 2028 average. Momentum favours further upside here.
GH Research PLC's 2030 outlook centres on $63.33, within a $45.09 to $96.34 range. That is up +8% on the projected 2029 average. That marks a +139% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, GHRS could reach as high as $110.31, with a base case around $70.73 and support toward $49.17 — roughly +167% from $26.51. Momentum favours further upside here.
Expect GHRS to range from $59.98 to $140.68 through 2032. The $88.23 average target implies a +233% move from current prices. That is up +25% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The GHRS price prediction for 2033 points to an average of $102.53 (low $68.25, high $166.81) — a potential gain of +287% on today's $26.51. Momentum favours further upside here.
In 2034, GHRS is projected to trade between $84.86 and $215.54, averaging $130.07 — a potential gain of +391% from today's $26.51. That is up +27% on the projected 2033 average. Buyers look set to stay in control over this stretch.
GH Research PLC's 2035 outlook centres on $154.37, within a $98.80 to $260.23 range. That is up +19% on the projected 2034 average. That marks a +482% change versus current levels. Momentum favours further upside here.
By 2040, GHRS could reach as high as $461.68, with a base case around $255.09 and support toward $149.40 — roughly +862% from $26.51. Buyers look set to stay in control over this stretch.
Expect GHRS to range from $256.66 to $1,028.71 through 2050. The $513.05 average target implies a +18.4x move from current prices. That is up +101% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in GHRS today (≈ 37.721614 GHRS) could be worth
$19,353
+$18,353 (+1835%) by 2050 · US Dollar
Based on the average projected GHRS price of $513.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GHRSwould be worth at today's price.
$1,000 invested in GHRS on Jul 10, 2025 (≈ 62.305299 GHRS) would be worth
$1,651.71
+$651.71 (+65.2%) today · 1.65× · US Dollar
Based on a GHRS entry price of $16.05 vs. today's $26.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.01 | $981.49 | -1.9% |
| 1 month ago | $20.36 | $1,302.06 | +30.2% |
| 3 months ago | $15.72 | $1,686.39 | +68.6% |
| 6 months ago | $15.21 | $1,742.93 | +74.3% |
| 1 year ago | $16.05 | $1,651.71 | +65.2% |
| All time (5.0y) ago | $17.72 | $1,496.05 | +49.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GHRS forecast.
Our base-case forecast reaches $53.00 around 2029.
Implied market cap at $53.00: $3.64B
The multi-year forecast shows a bullish trajectory, with 2030 avg $62.49 (min $43.46, max $97.42), 2040 avg $256.40 (min $142.67, max $481.21), and 2050 avg $502.66 (min $232.39, max $1,051.50). Forecasted ROI rises from 138.8% in 2030 to 879.8% in 2040 and 1820.8% in 2050, with sentiment described as BULLISH across these years. These figures are estimates, not guarantees, and actual results depend on clinical outcomes and regulatory decisions.
Tap a question to reveal the answer.
Avg $62.49; min $43.46; max $97.42; ROI 138.8%; sentiment BULLISH.
The forecast shows a bullish trajectory across years, with rising averages and substantial ROI by 2030–2050 and sentiment staying BULLISH, but these are estimates, not guarantees.
In 2030 the max is $97.42, and in 2031 the max is $111.96, so reaching $100 is within the forecast range based on the model.
The 30-day range is $20.51 to $33.39; RSI(14) is 60; SMA50 is $22.43 and SMA200 is $16.59; support is $19.98 and resistance is $28.49.
GH Research PLC Community Discussion
0Share your GH Research PLC price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.